Evidence map›Paper›PMID 26823883›Full record

ReviewInternational journal of clinical and experimental pathology2015

Acute promyelocytic leukemia with cryptic t(15;17) on isochromosome 17: a case report and review of literature.

Yuting Tang, Ying Wang, Liang Hu, Fankai Meng, Danmei Xu, Kai Wan, Lifang Huang, Chunrui Li, Jianfeng Zhou

Open access · greenAbstract readCase ReportsReview
In one paragraph

Review in International journal of clinical and experimental pathology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact, top 85% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Case reports in hematology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Yuting TangDepartment of Hematology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology 1095 Jie-Fang Avenue, Wuhan 430030, Hubei, P. R. China.
Ying WangDepartment of Hematology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology 1095 Jie-Fang Avenue, Wuhan 430030, Hubei, P. R. China.
Liang HuDepartment of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology 1095 Jie-Fang Avenue, Wuhan 430030, Hubei, P. R. China.
Fankai MengDepartment of Hematology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology 1095 Jie-Fang Avenue, Wuhan 430030, Hubei, P. R. China.
Danmei XuDepartment of Hematology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology 1095 Jie-Fang Avenue, Wuhan 430030, Hubei, P. R. China.
Kai WanDepartment of Hematology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology 1095 Jie-Fang Avenue, Wuhan 430030, Hubei, P. R. China.
Lifang HuangDepartment of Hematology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology 1095 Jie-Fang Avenue, Wuhan 430030, Hubei, P. R. China.
Chunrui LiDepartment of Hematology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology 1095 Jie-Fang Avenue, Wuhan 430030, Hubei, P. R. China.
Jianfeng ZhouDepartment of Hematology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology 1095 Jie-Fang Avenue, Wuhan 430030, Hubei, P. R. China.
Tongji Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute Promyelocytic Leukemia (APL) is one of the most curable leukemia which shows great sensitivity to all-trans retinoic acid (ATRA) although a small number of the patients present poor prognosis and short survival. Isochromosome 17 in APL which usually bears an additional copy of RARA/PML fusion gene is considered to be a negative factor on its prognosis. Cryptic t(15;17) on i(17q) leads to an extra copy of PML/RARA rather than RARA/PML which may confer a worse prognosis. We describe here a rare APL case with complex chromosomal abnormality including isochromosome 17 bearing cryptic t(15;17) showing poor outcome. The patient lacks a classic t(15;17) and fluorescence in situ hybridization (FISH) presents 2 PML/RARA fusion signals on both long arms of the isochromosome. The patient also acquired a secondary mutation at relapse when the initial karyotype was already a complex karyotype involving chromosome 13, 17 and 22 at the same time. The poor response of this patient to traditional chemotherapy like ATRA and novel therapy like arsenic trioxide (ATO) suggests that early auto-hematological stem cell transplantation may be the choice of APL with isochromosome 17 especially with cryptic t(15;17) on i(17q). We are the first to show a clear history and evidence of FISH of these kind of cases. A small summary of cases with cryptic t(15;17) on isochromosome 17 is also made.

Indexed as

Chromosomes, Human, Pair 15Chromosomes, Human, Pair 17IsochromosomesTranslocation, GeneticAntineoplastic AgentsArsenicalsArsenic TrioxideBone Marrow ExaminationDisease ProgressionFatal OutcomeGenetic Predisposition to DiseaseHumansIn Situ Hybridization, FluorescenceKaryotypeLeukemia, Promyelocytic, AcuteMaleAntineoplastic AgentsArsenicalsArsenic TrioxideOncogene Proteins, FusionOxidespromyelocytic leukemia-retinoic acid receptor alpha fusion oncoproteinTretinoinAcute promyelocytic leukemiacomplex karyotypecryptic insertionisochromosome 17

Identifiers

PMID26823883
PMCPMC4713669
OpenAlexW2411983041

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.